Business Information
The group's principal activity is to develop and commercialize women's health care and endocrinology products, including those used in treating infertility, dysmenorrhea, endometriosis and hormonal deficiencies and preventing pre-term birth. Its products include striant (testosterone buccal system), prochieve 8% or crinone 8% (progesterone gel) and prochieve 4% (progesterone gel). These products are delivered through its proprietary bioadhesive delivery system (bds) that enables controlled, sustained release of hormones, peptides and other difficult-to-deliver compounds. They are sold under the trademarks striant, striant sr, crinone and prochieve. The group's sales force also promotes advantage-s bioadhesive contraceptive gel, replens vaginal moisturizer and rephresh vaginal gel on behalf of lil' drug store products. Its direct customers include drug wholesalers and chain drug stores. The products are marketed in the United States and Europe.
|
|
Name |
Title
|
Email
|
| Edward Blechschmidt | Vice Chmn. | Available | | Stephen Kasnet | Chmn. | N/A | | Carl Worrell | Head - Sales, Marketing | N/A | | James Meer | Sr. VP, CFO, Treasurer | N/A | | George Creasy | VP - Clinical Research, Development | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 17,393 | (12,612) | | 2005 | 22,041 | (9,307) | | 2004 | 17,860 | (25,130)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
